Variables | Group A (%) | Group B (%) | Group C (%) | P |
---|---|---|---|---|
n = 370 | n = 194 | n = 973 | ||
Mean age, year (SD) | 46.86 ± 13.05 | 47.03 ± 11.26 | 48.43 ± 13.73 | 0.090a |
Age ≥ 50 (%) | 157 (22.6) | 74 (10.7) | 463 (66.7) | 0.026b |
Gender | 0.860b | |||
Male | 204 (55.1) | 110 (56.7) | 531 (54.6) | |
Female | 166 (44.9) | 84 (43.3) | 442 (45.4) | |
ALT ≥40 U/L | 104 (28.1) | 27 (13.9) | 48 (4.9) | <0.001c |
AST ≥ 40 U/L | 128 (34.6) | 30 (15.5) | 80 (8.2) | <0.001c |
High-risk population | <0.001b | |||
Drug user | 155 (41.9) | 36 (18.6) | 246 (25.3) | |
HD | 74 (20.0) | 89 (45.9) | 551 (56.6) | |
PBD | 141 (38.1) | 69 (35.6) | 176 (18.1) | |
HCV genotypes | <0.001b | |||
1 | 236 (63.8) | 114 (58.8) | – | |
Non-1 | 51 (13.8) | 53 (27.3) | – | |
Mixed | 83 (22.4) | 27 (13.9) | – |